SCIENCE IN THE NEWS DAILY
Erbitux OK for Colorectal Cancer Patients with Genetic Marker
from USA Today
A new study shows which colorectal cancer patients may benefit from a drug - and which would be better off without it.
The drug Erbitux doesn't work in patients whose tumor has a certain genetic mutation, according to a study of nearly 600 patients, presented Sunday at the annual meeting of the American Society of Clinical Oncology in Chicago.
About 36 percent of patients in the study have the mutation, in a gene called KRAS, says co-author Eric Van Cutsem, of University Hospital Gasthuisberg in Belgium. All of the patients in the study had colorectal cancer that had spread to other organs.
Read more ...
Connect With Us:
VIDEO: How Hair Ice Grows
In 2013, American Scientist featured an article on odd ice formations on plant stems, including these curling ribbons of ice. One of the types of ice discussed in the article was hair ice—long, thin strands of ice that grow under quite specific conditions. The only problem is that a new study shows the theory put forth at the time—that gas pressure pushes the water out—isn’t correct... (click the link above to read more).
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.